InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Nader Francois, Director. Officer active across 5 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 8 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €344k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 19 July 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nader Francois
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
50,000 shares@ US$3.5250.0% of flowCommon StockSEC:0000899243-22-030924:0
Canonical exit: 17 Oct 2022 (T+90)
50,000 shares@ US$3.5250.0% of flowCommon StockSEC:0000899243-22-026684:0
Canonical exit: 17 Oct 2022 (T+90)
23,100 shares@ US$18.870.0036% mcap100.0% of flowCommon StockSEC:0001127602-22-014263:0
703 shares0Common StockSEC:0001127602-22-012857:0
59,520 shares0Common StockSEC:0000899243-21-048599:0
6,749 sharesCommon StockSEC:0001104659-21-142272:0
13,921 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000065:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000043:0
8 of 8 declarations
About Nader Francois
Francois Nader is a Board Member of ALEXION PHARMACEUTICALS, INC., ACCELERON PHARMA INC, and Talaris Therapeutics, Inc. He plays a key role in the governance of these companies and brings his expertise in strategy and business development.
